ORANGE COUNTY
From Times Staff and Wire Reports
Fiscal Year Loss: Cortex Pharmaceuticals Inc., an Irvine-based neurological drug company, reported a loss of $2.4 million, or 18 cents a share, for its fiscal year ended June 30. That compared to a loss of $2.6 million, or 20 cents a share, for the previous 12 months. Annual operating revenue was $1 million, up from $33,712. For the fourth quarter, the company posted a loss of $415,619, or 3 cents a share, compared to a loss of $839,419, or 7 cents a share, for the same period a year earlier. Revenue rose to $500,000.
